Seggewiss Jochen, Becker Karsten, Kotte Oliver, Eisenacher Martin, Yazdi Mohammad Reza Khoschkhoi, Fischer Andreas, McNamara Peter, Al Laham Nahed, Proctor Richard, Peters Georg, Heinemann Matthias, von Eiff Christof
Institute of Medical Microbiology, University Hospital of Münster, Domagkstrasse 10, 48149 Münster, Germany.
J Bacteriol. 2006 Nov;188(22):7765-77. doi: 10.1128/JB.00774-06. Epub 2006 Sep 15.
In this study, full-genome DNA microarrays based on the sequence of Staphylococcus aureus N315 were used to compare the transcriptome of a clinical S. aureus strain with a normal phenotype to that of its isogenic mutant with a stable small-colony-variant (SCV) phenotype (hemB::ermB). In addition to standard statistical analyses, systems biology advances were applied to identify reporter metabolites and to achieve a more detailed survey of genome-wide expression differences between the hemB mutant and its parental strain. Genes of enzymes involved in glycolytic and fermentative pathways were found to be up-regulated in the hemB mutant. Furthermore, our analyses allowed identification of additional differences between the normal-phenotype S. aureus and the SCV, most of which were related to metabolism. Profound differences were identified especially in purine biosynthesis as well as in arginine and proline metabolism. Of particular interest, a hypothetical gene of the Crp/Fnr family (SA2424) that is part of the arginine-deiminase (AD) pathway, whose homologue in Streptococcus suis is assumed to be involved in intracellular persistence, showed significantly increased transcription in the hemB mutant. The hemB mutant potentially uses the up-regulated AD pathway to produce ATP or (through ammonia production) to counteract the acidic environment that prevails intracellularly. Moreover, genes involved in capsular polysaccharide and cell wall synthesis were found to be significantly up-regulated in the hemB mutant and therefore potentially responsible for the changed cell morphology of SCVs. In conclusion, the identified differences may be responsible for the SCV phenotype and its association with chronic and persistent infections.
在本研究中,基于金黄色葡萄球菌N315序列的全基因组DNA微阵列被用于比较具有正常表型的临床金黄色葡萄球菌菌株与其具有稳定小菌落变体(SCV)表型(hemB::ermB)的同基因突变体的转录组。除了标准的统计分析外,还应用了系统生物学进展来鉴定报告代谢物,并更详细地调查hemB突变体与其亲本菌株之间全基因组表达差异。发现参与糖酵解和发酵途径的酶基因在hemB突变体中上调。此外,我们的分析还确定了正常表型金黄色葡萄球菌和SCV之间的其他差异,其中大部分与代谢有关。特别是在嘌呤生物合成以及精氨酸和脯氨酸代谢方面发现了显著差异。特别值得关注的是,Crp/Fnr家族的一个假定基因(SA2424)是精氨酸脱亚氨酶(AD)途径的一部分,其在猪链球菌中的同源物被认为参与细胞内持续存在,在hemB突变体中显示出转录显著增加。hemB突变体可能利用上调的AD途径产生ATP或(通过产生氨)来对抗细胞内普遍存在的酸性环境。此外,发现参与荚膜多糖和细胞壁合成的基因在hemB突变体中显著上调,因此可能是SCV细胞形态改变的原因。总之,所确定的差异可能是SCV表型及其与慢性和持续性感染相关联的原因。